Decoy androgen-responsive element DNA can inhibit androgen receptor transactivation of the PSA promoter gene

Pengju Zhang1, Jianye Zhang, Charles Y F Young

  • 1Institute of Biochemistry and Molecular Biology, School of Medicine, Shandong University, Jinan 250012, People's Republic of China.

Insights

Decoy DNA targeting androgen receptors (ARs) effectively suppressed their activity in prostate cancer cells. This finding suggests a potential new therapeutic strategy for prostate cancer treatment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Androgen receptors (ARs) play a crucial role in prostate cancer progression.
  • Current treatments like chemotherapy and hormonal therapy have significant side effects.
  • Inhibiting AR activity presents a potential therapeutic avenue for prostate cancer.

Purpose of the Study:

  • To investigate the efficacy of a prostate-specific antigen (PSA) androgen-responsive element (ARE) decoy DNA in inhibiting AR function.
  • To assess the potential of decoy DNA as a novel therapeutic strategy for prostate cancer.

Main Methods:

  • Utilized a Dual-Luciferase Assay System with a PSA ARE decoy DNA sequence.
  • Co-transfected human prostate cancer cells (PC3-M) with a reporter plasmid (PSA promoter driving luciferase) and the decoy DNA.
  • Measured luciferase activity after androgen exposure to determine the inhibitory effect of the ARE decoy.

Main Results:

  • Significant reduction in luciferase activity was observed in cells transfected with the ARE decoy DNA.
  • Control decoy DNA did not show a significant inhibitory effect.
  • The results demonstrate that ARE decoy DNA effectively suppresses androgen-activated ARs in prostate cancer cells.

Conclusions:

  • Androgen-responsive element decoy DNA can effectively inhibit androgen receptor activity in prostate cancer cells.
  • Decoy DNA holds promise as a potential novel therapeutic approach for prostate cancer.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...